LONDON, Nov. 29, 2021 /PRNewswire/ -- Kheiron Medical Technologies today announced its new collaboration with researchers at Stanford University to design functional proof-of-concept deep learning ...

Kheiron Medical Technologies, is an applied science company, announced its new collaboration with researchers at Stanford University to design functional proof-of-concept deep learning models to solve ...

Founded in 2016, Kheiron Medical Technologies is helping radiologists detect breast cancers earlier with its AI screening product. Joining Julia to discuss is Kheiron CEO Dr. Peter Kecskemethy.

VIENNA, March 1, 2019 /PRNewswire/ -- European Congress of Radiology - AI diagnostics company Kheiron Medical is today announcing the launch of Mia ™, a breast cancer screening solution that ...

An artificial intelligence (AI) breast screening solution called Mia helped doctors find an additional 12% more cancers than in routine practice, as announced today in collaboration with Kheiron ...

Article ‘Count’ and ‘Share’ for Kheiron Medical Technologies based on listed parameters only. The articles listed below published by authors from Kheiron Medical Technologies, organized by ...

Created by Kheiron Medical Technologies, the Mia® AI-enabled breast screening solution received regulatory clearance in Australia and New Zealand.

Kheiron and AI Advance are currently working with an Australian breast-screening provider to establish the protocols for a forthcoming clinical trial, details of which will soon be announced.

CHICAGO, Nov. 27, 2018 /PRNewswire/ -- RSNA - Kheiron Medical Technologies has been granted government funding to test its deep learning breast cancer screening software within the NHS.